Cargando…
Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis
BACKGROUND: The effects of pharmacological blood pressure lowering at normal or high-normal blood pressure ranges in people with or without pre-existing cardiovascular disease remains uncertain. We analysed individual participant data from randomised trials to investigate the effects of blood pressu...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8102467/ https://www.ncbi.nlm.nih.gov/pubmed/33933205 http://dx.doi.org/10.1016/S0140-6736(21)00590-0 |
Ejemplares similares
-
Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis
Publicado: (2021) -
Identifying Individuals at Risk for Cardiovascular Events Across the Spectrum of Blood Pressure Levels
por: Karmali, Kunal N, et al.
Publicado: (2015) -
Blood pressure-lowering treatment strategies based on cardiovascular risk versus blood pressure: A meta-analysis of individual participant data
por: Karmali, Kunal N., et al.
Publicado: (2018) -
Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis
por: Nazarzadeh, Milad, et al.
Publicado: (2022) -
Blood pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation: An individual participant data meta-analysis
por: Pinho-Gomes, Ana-Catarina, et al.
Publicado: (2021)